Anaconda Biomed Secures $56 Million Financing from New and Existing Investors
Proceeds used to complete ongoing ATHENA pivotal IDE study, continue product development, and secure global regulatory approvals for ne...
ANA5 Funnel Catheter has received the CE Mark certification
Anaconda Biomed is proud to announce that its ANA5 Funnel Catheter has been awarded CE Mark certification, ...
Welcome Dr. Chuck Carignan as our new Chairman
We are pleased to announce the appointment of Dr. Chuck Carignan as Chairman of our company. With deep expertise in clinical practice, ...
Our CEO Trent Reutiman presents Anaconda Biomed at LSI USA ’25 Emerging Medtech Summit in Dana Point, California.
Our CEO Trent Reutiman presents Anaconda Biomed and the ANA Funnel Catheter at LSI USA '25 Emerging Medtech Summit in Dana Point, Calif...
We have enrolled the first U.S. patient in the ATHENA clinical trial evaluating the ANA funnel catheter for the treatment of ischemic stroke.
ATHENA is a global, randomized 327-patient pivotal study evaluating the safety and effectiveness of Anaconda’s proprietary ANA Funnel C...